Oncology Venture investerarmöten under andra kvartalet 2019

NEXT STORY
Global Opioids Market to Reach $29.4 Billion by 2024 – Asia Pacific is Expected to Witness the Fastest Growth Over the Forecast Period
PREV STORY
Forty Seven Inc. Expands Collaboration with Genentech to Include Third Clinical Trial in Non-Hodgkin’s Lymphoma
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Oncology Venture investerarmöten under andra kvartalet 2019

NEXT STORY
Global Opioids Market to Reach $29.4 Billion by 2024 – Asia Pacific is Expected to Witness the Fastest Growth Over the Forecast Period
PREV STORY
Forty Seven Inc. Expands Collaboration with Genentech to Include Third Clinical Trial in Non-Hodgkin’s Lymphoma
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Bavarian Nordic Enters Agreement with AdaptVac to Advance COVID-19 Vaccine Program

author_avatar
NASDAQ Market News

Lipocine Announces the Presentation of Clinical Data for LPCN 1021, Its Oral Testosterone Replacement Therapy Product Candidate, at ENDO 2016

SALT LAKE CITY, March 28, 2016 (GLOBE NEWSWIRE) -- Lipocine Inc. (NASDAQ:LPCN), a specialty ...

author_avatar
NASDAQ Market News

Ritter Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update

LOS ANGELES, March 19, 2018 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) (“Ritter ...

author_avatar
NASDAQ Market News